All Comments by Liana Apostolova
- And Then There Were Three: Donanemab Phase 3 Trial Positive
- Dare We Say Consensus Achieved: Lecanemab Slows the Disease
- A 3-D View of One of Neuroscience's Most Famous Brains
- Insurance Coverage of AD Diagnostics? Not Without Better Data
- FDA Approves Amyvid for Clinical Use
- MCI—Hippocampal IDE, Parahippocampal White Matter in Decline